Technical Stock Pick: Should you buy this FY24 multibagger pharma stock after recent dip?
Aurobindo Pharma's stock, after a 100% rally in FY24, faced resistance but is now showing signs of bottoming out. Experts suggest a possible rise above Rs 1,300 for short-term traders.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
